Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
trastuzumab deruxtecan
×
Clear all
Filters
2
NCT05982678
2025-11-26
ANISE
The Netherlands Cancer Institute
Phase 2
Recruiting
72 enrolled
NCT05458401
2024-03-15
EUROPA T-DXd
Daiichi Sankyo
Completed
256 enrolled